Doctors worry about FDA scrutiny of RSV shots to protect babies

NPR
March 25, 2026
1 min read

Quick Insights

The Bottom Line

FDA scrutiny of RSV monoclonal antibody shots may affect their availability to infants, despite 80% effectiveness.

How This Affects You

If you have an infant or high-risk newborn, potential FDA restrictions on RSV antibody shots could limit access to preventive treatment that reduces intensive care admissions by 80%.

AI Summary

Doctors are expressing concern about potential FDA scrutiny of RSV monoclonal antibody shots designed to protect infants from respiratory syncytial virus infection. The antibody medications are approximately 80% effective at preventing babies from requiring intensive care due to RSV, according to available data. Drugmakers producing the shots maintain the treatments are safe, though the FDA review could affect their availability or use in clinical practice. The outcome of the agency's examination will likely influence pediatric treatment protocols for RSV prevention in high-risk infant populations.

Following this story?

Get notified when new coverage appears

Should this be getting more attention?

You Might Have Missed

Related stories from different sources and perspectives

Trump and RFK Jr touted leucovorin as a treatment for autism. The FDA quietly walked it back
Health

Trump and RFK Jr touted leucovorin as a treatment for autism. The FDA quietly walked it back

<p>Outpatient prescriptions for the drug increased 71% after the announcement, but the FDA later approved it only for folate deficiency </p><p>When Donald Trump and Robert F Kennedy Jr stood up at the press conference in September to tout leucovorin, a vitamin B derivative, as a treatment for autism, some neurodevelopmental doctors were shocked – and they braced themselves. There was little evidence to suggest the folinic acid helps with autism, yet there was an immediate flood of parents calling and scheduling visits to talk about the medication.</p><p>“The average parent who maybe wasn’t getting the right information said, ‘Well, to be good parents, we need to try this,’” said William Graf, a professor of pediatrics and neurology at Connecticut Children’s Medical Center. Outpatient leucovorin prescriptions for children ages five to 17 in the US rose by 71% in the weeks following the announcement, new <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00243...

The Guardian US NewsMar 22
When Voters Worry About ‘Affordability,’ Many Point to Health Care
Politics

When Voters Worry About ‘Affordability,’ Many Point to Health Care

Democrats have had limited political success running on the Affordable Care Act, even with its relative popularity. Now President Trump’s health care cuts may have given the issue new resonance.

New York TimesMar 23
More parents are refusing routine newborn preventative care, study finds
Health

More parents are refusing routine newborn preventative care, study finds

Doctors fear that skepticism, fueled by anti-science sentiment and mistrust, is extending beyond vaccines to other proven, routine care.

CBS NewsMar 21
When Voters Worry About ‘Affordability,’ Many Point to Health Care - The New York Times
Health

When Voters Worry About ‘Affordability,’ Many Point to Health Care - The New York Times

The New York TimesMar 23
As demand for GLP-1 pills and shots surges, healthy habits are still key - AP News
Health

As demand for GLP-1 pills and shots surges, healthy habits are still key - AP News

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQT0s3R0ljMy1ZNXdOQUxvdHBjWERVUTNUNFpPTEVtVWNmM0E3clN0TGpIWnFWRlFxWFB2elBleW5OU1VaU050UWJNbE1yc1M2R3QxcXBVbEhiMF8zbTVPazhESDZJMUE3V2dfMGRjYTZzNDlhdndLdnAyQU5JLV9BTjVPc0N1NGlFTHNNM29LVlpVdzU0?oc=5" target="_blank">As demand for GLP-1 pills and shots surges, healthy habits are still key</a>&nbsp;&nbsp;<font color="#6f6f6f">AP News</font>

AP NewsMar 23
Better NHS care might have saved 58 babies, BBC finds
Health

Better NHS care might have saved 58 babies, BBC finds

There are growing calls for a statutory public inquiry into maternity services in Oxford.

BBC NewsMar 19
Read Next
Meta and YouTube Found Negligent in Landmark Social Media Addiction Trial
Health

Meta and YouTube Found Negligent in Landmark Social Media Addiction Trial

A jury found the companies negligent in their app designs, harming a young user with design features that were addictive and led to her mental health distress.

Continue reading

Did this story change how you see things?

Stories like this only matter when people see them. Help us get verified journalism in front of more eyes.

Share this story

Get the daily digest

Save for later

The Verity Ledger curates verified investigative journalism from trusted sources only.

See our sources